The FDA's Flawed Approach: A Recipe for Regulatory Overreach?
The recent Bombay high court rap of the Maharashtra Food and Drug Administration (FDA) over its handling of cases involving five MCA eateries and a Cipla facility has exposed a disturbing trend in regulatory decision making.
On closer inspection, this appears to be more than just isolated incidents of bureaucratic ineptitude. One striking aspect is the FDA's tendency to prioritize strict adherence to rules over practical considerations.